NovaSeq™ has enabled researchers to employ novel experimental approaches to explore genetic variation associated with health and disease. The throughput and compelling economics of the new platform are enabling broader and deeper studies, many of which weren’t practical even a few years ago. Illumina continues to invest in the new system with the goal of enabling an even greater range of sequencing methods and applications. Today, Illumina announced two extensions to its core consumables portfolio for the NovaSeq 6000 Sequencing System.
“We actively seek customer feedback regarding how we can further extend and enhance the capabilities of NovaSeq. The new SP Flow Cell and S4 Cycle Kit configuration are a direct result of their input,” shared Joel Fellis, Director, Product Marketing, Sequencing Systems at Illumina. “The new products offer customers additional flexibility to leverage a single sequencing platform to address a wide range of experiment types and applications.”
The NovaSeq 6000 Sequencing System now offers four different flow cells: SP, S1, S2 and S4. Users can mix and match flow cells and kit configurations to most efficiently execute their experimental plan. To learn more about the advantages of the NovaSeq, the S4 200 Cycle Kit, and the SP Flow Cell, please visit www.illumina.com/NovaSeq. These products are expected to be available in Q4 2018.
For Research Use Only. Not for use in diagnostic procedures.